Skip to content

Perioperative effects of acupoint stimulation on high-risk patients with postoperative nausea and vomiting

Perioperative effects of acupoint stimulation on high-risk patients with postoperative nausea and vomiting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070022
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PONV

Interventions

Antiemetic group:Ondansetron 8 mg intravenously administered before the end of surgery
Transcutaneous acupoint electrical stimulation group:After anesthesia induction, percutaneous electrical stimulation of Neiguan, Hegu, and Zusanli acupoints for 30 minutes
Percutaneous acupoint electrical stimulation combined with pressing needle group:Percutaneous acupoint electrical stimulation combined with postoperative pressing acupuncture at Neiguan, Hegu, and Zus

Sponsors

Shaoxing people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged 20-50 who undergo laparoscopic cholecystectomy. 2. No history of smoking or motion sickness. 3. ASA classification I-II. 4. Persons without a history of serious systemic diseases.

Exclusion criteria

Exclusion criteria: 1. Have received acupoint stimulation treatment within 1 month before surgery. 2. People with skin infection or damage at acupoints. 3. Unable to cooperate with pressing acupuncture points to massage patients after surgery. 4. Those who have undergone surgery for more than 2 hours or have undergone conversion to laparotomy.

Design outcomes

Primary

MeasureTime frame
Frequency and severity of nausea and vomiting;

Secondary

MeasureTime frame
Pain VAS score;Duration of first postoperative exhaust, first defecation, and flatulence;Heart rate variability at 48 hours before and after surgery;Blood indicators such as motilin, interleukin-6, and norepinephrine;

Countries

China

Contacts

Public ContactLv Anqing

Shaoxing people's Hospital

515812382@qq.com13735373573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026